Also trades as: MMED (NASDAQ) · $vol 97M
MMEDV NASDAQ
MiniMed Group, Inc.
1W: -7.3%
YTD: -5.3%
$17.70
+0.00 (+0.00%)
After Hours: $18.85 (+1.15, +6.50%)
Credit Risk of going bust: not rated Debt: 1.1% of company value Bonds: none of note held by US funds details ▾
Not rated: insufficient price history.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$495.6M
52W Range15.5-21.5
Volume226,896
Avg Volume51,841
Beta-2.86
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOQue Thanh Dallara
Employees8,000
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2026-10-01
Websiteminimed.com
18000 Devonshire Street
Northridge, CA 91325
US
Northridge, CA 91325
US
About MiniMed Group, Inc.
MiniMed Group, Inc. is a medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Its products include insulin delivery devices like pumps and pens, continuous glucose monitors, and related software and services. The company serves people with diabetes who require insulin therapy across more than 80 countries.
Latest News
Recent Insider Trades
No insider trades found